Multiple Human Papillomavirus Infections in Routine Cytology-based Cervical Screening and Histology Practice: Epidemiology and Histomorphological Investigations by Kovács Krisztina
 
 
MULTIPLE HUMAN PAPILLOMAVIRUS INFECTIONS IN ROUTINE 
CYTOLOGY-BASED CERVICAL SCREENING AND HISTOLOGY PRACTICE: 
EPIDEMIOLOGY AND HISTOMORPHOLOGICAL INVESTIGATIONS 
 
 
 
 
 
 
 
Ph.D. Thesis 
 
 
 
 
 
 
 
Dr. Krisztina Kovács 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
UNIVERSITY OF PÉCS 
FACULTY OF MEDICINE 
 
 
 
PÉCS 
 
2009

 
 
MULTIPLE HUMAN PAPILLOMAVIRUS INFECTIONS IN ROUTINE 
CYTOLOGY-BASED CERVICAL SCREENING AND HISTOLOGY PRACTICE: 
EPIDEMIOLOGY AND HISTOMORPHOLOGICAL INVESTIGATIONS 
 
 
Ph.D. Thesis 
 
 
 
 
 
Dr. Krisztina Kovács 
 
 
 
 
 
Doctoral School:....................... Clinical Medicine 
Director of Doctoral School: .... Prof. Dr. Samuel Komoly 
PhD programme: ...................... Molecular pathomorphology 
Advisory Tutor: ........................ Prof. Dr. László Pajor 
Consultant: ............................... prof. Dr. Reinhard Bollman 
 
 
 
 
 
 
 
 
UNIVERSITY OF PÉCS 
MEDICAL CENTER 
DEPARTMENT OF PATHOLOGY 
 
 
PÉCS 
 
2009 
ABBREVATIONS 
 
AEC.............................. amino-ethyl-carbasol 
AP................................. alkaline phosphatase 
ASCUS......................... Atypical Squamous Cells of Undetermined Significance 
BCIP ............................. bromo-chloro-indoyl-phosphate 
BLAST ......................... Basic Local Alignment Search Tool 
bp.................................. base pair 
CI.................................. confidence interval 
CIN............................... cervical intraepithelial neoplasia 
CISH............................. chromogenic in situ hybridization 
DIG............................... digoxigenin 
DNA ............................. deoxyribonucleic acid 
E region/gene................ early region /gene  
FAM ............................. 6-Carboxyfluorescein 
H&E ............................. hematoxilin and eosin 
HPV.............................. Human papillomavirus 
HR- ............................... high-risk- 
HRP .............................. horseradish peroxidase 
HSIL ............................. high grade squamous intraepithelial lesion 
IHC............................... immunohistochemistry 
INNO-LiPA.................. Innogenetics Line Probe Assay 
ISH ............................... in situ hybridization 
L region/gene................ late region/gene 
LA................................. Linear Array 
LBC .............................. liquid based cytology 
LR- ............................... low-risk - 
LSIL ............................. low grade squamous intraepithelial lesion 
NBT.............................. nitroblue tetrasolium 
OR ................................ Odds ratio 
PCR .............................. Polymerase Chain Reaction 
UR- ............................... unknown-risk - 
VAIN............................ vaginal intraepithelial neoplasia 
WHO ............................ World Health Organisation  
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INTRODUCTION 
 
In our present knowledge the vast majority of cervical carcinoma and its precursors 
worldwide are causally associated with persistent infections by high-risk human 
papillomaviruses (HR-HPV). Recent studies of the biological behaviour of viri and the natural 
history of HPV infections have reflected on the importance of genotyping, especially 
regarding the fact, that a significant proportion of infections are caused by different genotypes 
transiently and consecutively. 
 20–40% of HPV-positive women are reported to be infected with multiple HPV types.  
Epidemiologic studies of multiple infections, in the light of recent findings on possible 
synergism between HPV types in the induction and progression of cervical lesions and in an 
era where HPV vaccination commences have significance. Longitudinal studies have 
suggested that the one time, cross-sectional detection of HPV types may underestimate the 
cumulative diversity of exposure to HPV in the long term.  
At the moment there is no “gold standard” for HPV detection and genotyping. Despite 
its recognised high analytical sensitivity, the worldwide used consensus PCR-based protocols 
may have missed cases harbouring a virus load lower than the threshold of detection. There is 
also a significant proportion of women who had positive results by consensus - PCR but their 
sample was not tested by genotyping, due to many reasons. 
The apparent disparity in HPV prevalence in the literature highlights the fact that rates of 
HPV infection in a specific setting vary considerably according to many factors, such as the 
characteristic of investigated population and the HPV detection methods. 
In routine diagnostic practice, several possible applications and combinations of new 
visual, microscopical, and virological screening methods have already been applied for the 
prevention of cervical cancer. However, even colposcopy and the highly sensitive ancillary 
tests of combined cytology and HPV genotyping cannot define the specific areas of the cervix 
where the specific HPV - type is contained, and where the least regressive CIN3/CIS is 
located, especially in the cases of multiple HPV infections. Only the histological examination 
may be able to confirm the distributional localisation of different genotypes and the grade of 
different HPV - induced squamous lesions. 
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AIMS  
 
Based on the statistical analysis of data obtained from patients followed in the risk-adapted 
screening program of Germany’s Bonn region and the re-evaluation of their histological 
samples, we sought answers to the following questions: 
 
I. Epidemiologic characteristics of multiple HPV infections 
 
a) What is the frequency of multiple HPV infections within the examined population and 
what is the distribution of genotypes? 
b) Are there differences between methods used for virus detection regarding the number 
of  different, identifiable HPV genotypes? 
c) Are there differences between different age-groups regarding the incidence and 
prevalence? 
 
II. Characteristics of persistent HPV infections 
 
a) What are the cytologic and histologic characteristics of persistent infections lasting 
significantly longer than the elimination period, that are caused by a single genotype? 
b) Are the differences between genotypes regarding the duration of the infection? 
c) What are the differences between infections caused by a single or multiple HPV 
genotypes? 
 
III. Morphological spectrum of lesions of the uterine cervix infected by multiple HPV 
 genotypes – viral detection 
 
a) What kind of histological lesions can be identified in cases of multiple HPV infection? 
b) Can the presence of HPV be demonstrated at the histological level? 
c) Can the different genotypes be localised histologically? What is the topographical 
distribution of the different genotypes? 
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MATERIAL AND METHODS 
 
Patients and samples  
Cytological and histological samples of patients selected from the population of 7.5 years of 
routine gynecological oncocytological screening based on elevated risk for cervical cancer 
were used for the purposes of the study. 11971 liquid-based cytological samples of 8090 
patients and the HPV DNA tests performed from the samples were analysed. 
 
I. phase: 489 multiple HPV infected women, 592 HPV DNA test, 589 cytology; 
histological examination in127 patients 
II. phase: 6017 LBC sample and HPV DNA test of 2136 women: 100 women / 415 HPV 
DNA test; histology in 46 patients 
III. phase: 97 histological preparations of 127 women; 12 patients /histology (HPV16+31) 
 
Diagnostic procedures and methods 
1) Cytology: For liquid-based cytology (thin-layer) preparations were made using the 
ThinPrep 2000 processor. Cytological diagnoses were classified according to the modified 
Munich II Cytological classification and converted into the Bethesda 2001 terminology. 
 
2) HPV DNA detection was directly performed from residual liquid-based cytology material 
by 5 different PCR-based assays: 
 
a) PCR-based HPV DNA detection and genotyping by sequencing: PCR-based assays using 
the MY09/MY11 consensus primers and the GP5+/6+ general primer system in combination 
with automated PCR fragment analysis. Results were compared with documented virus 
sequences available in GenBank database using the BLAST program. 
 
b) HPV type-specific PCR: Type specific PCR was performed for the common HPV types 6, 
11, 16, 18, 31, 33, and 51 according to published protocols [van den Brule et al., 2002] with 
modifications [Speich et al., 2004]. All forward primers used in PCRs were labeled with 
FAM; this allowed analysis of PCR fragments by fluorescence capillary electrophoresis. 
 
c) Roche Linear Array HPV genotyping test: involves PCR amplification of target DNA, 
followed by nucleic acid hybridization using a reverse line blot system for the simultaneous 
detection of 37 anogenital HPV genotypes. The LA HPV genotyping test amplifies a region 
of approximately 450 bp in length within the L1 gene of the HPV genome. 
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d) INNO-LiPA HPV genotyping v2 test: is able to detect 24 HPV types by hybridization of an 
amplified fragment of the HPV L1-region to immobilized oligonucleotides on a membrane 
strip. 
 
e) PapilloCheck test: is based on the detection of an amplified fragment of the E1 gene of 
HPV. For analysis of the data the CheckReport analysis-software was used. The PapilloCheck 
Test detects 24 HPV types. 
 
3) Histology  
Gross and histological processing of surgical specimens were performed according to 
standardised surgical pathology protocols, histological diagnoses were made using the WHO 
(1975) and CIN (Richart) classification. 
 
a) H&E staining: conventional 
 
b) Immunohistochemical detections (IHC): 
 • p16 INK4a : Detection of human p16 INK4a protein was performed using CINtec 
  p16INK4a antibody (mtm Laboratories, Germany). 
 
• Ki67: (Mib1) Demonstration of HPV-induced cell proliferation (NeoMarkers, 
              Fremont, USA). 
 
• Detection of HPV L1 capsid protein: The reactions were performed using the 
  Cytoactive® HPV Screening Set (Cytoimmun, Germany) as recommended by the 
  manufacturer. 
 
All tests were done using standard, streptavidin-biotin-peroxidase based indirect technique as 
recommended by the manufacturer. 
 
c) In situ hybridisation (ISH): To characterise the histo(cyto)morphological and molecular 
basic features of HPV infection, the following techniques were used: 
- INFORM HPV III Family 16 Probe (B) ISH:  was used in the BenchMark Staining 
   Platform (Ventana Medical Systems) according to recommendations of the 
   manufacturer. The probe cocktail has demonstrated affinity to the following HPV 
   genotypes: 16, 18, 31, 33, 35, 39, 51, 52, 56, 58 and 66. 
- manually: a) HPV16 biotin, b) HPV31 digoxigenin labelled probes were used with  
   a) avidin-HRP + AEC,  b) anti-dig-AP + NBT/BCIP enzyme-substrate reactions. 
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RESULTS AND CONCLUSIONS 
 
I. Epidemiologic characteristics of multiple HPV infections 
 
In the present study, the prevalence and type-specific composition of multiple HPV 
infections were investigated in a risk adapted, multimodal protocol based routine cervical 
screening population from the federal state North Rhine-Westphalia in West Germany both at 
a cross-sectional level and longitudinally.  
Four hundred eighty-nine out of 8090 women were diagnosed with multiple HPV 
infections once or repeatedly. During the 7.5-year study period, the cumulative prevalence of 
HPV co-infections was 15.3% in contrast to the cross-sectional prevalence of 3.8% at single 
visits. The overall cumulative prevalence within the cohort of all women screened was 6.9%.  
Using consensus PCR with sequencing and type-specific PCRs, two to three HPV types were 
detected simultaneously, whereas broad spectrum methods detected up to seven different 
genotypes in one sample. Nevertheless, the most common pattern of co-infection occurred 
with two to three HPV types irrespective of the age of the patient, cytology and histology of 
the lesions and the method used. Altogether, 45 different HPV genotypes were detected using 
different HPV detection methods. The most common genotypes detected were HPV16, 31, 
53, 51, 52, and 66, and the most common pattern of co-infection was double infection with 
HPV16 and 31.  
The highest prevalence of multiple HPV infection occurred in women between 25 and 
34 years of age (35.5%). There was no significantly increased risk for multiple HPV infection 
in younger women (<30 years) over the older ones. 
The prevalence of multiple HPV infection was significantly lower in HSIL (14.7%) 
than in LSIL (45.7) and ASCUS (39.6%) respectively. 
Histologically, the highest prevalence of multiple HPV infection was detected in high 
grade cervical intraepithelial neoplasias (CIN3; 43.3%). 
 
Our results show that rates and patterns of multiple HPV infections are largely dependent on 
the methodology used and the time interval between tests.  
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II.  Study of longer than 18 months type-specific human papillomavirus persistence 
 
In this phase of the study from a screening population of 8090 women, a strictly 
selected cohort of 100 patients with ≥18-month persistent, type-specific HPV infection were 
prospectively followed-up for a mean of 35.52 months (± 13.0).  
Altogether, 21 different genotypes were detected. Seventy-two percent of women were 
infected with high-risk (HR)-HPVs, 24% with low-risk (LR)- and 4% with unknown risk 
(UR)-HPV types. The mean duration of infections showed considerable variation among the 
different HPV types and risk groups detected and ranged between 19.7 and 54.3 months. 
44% of cases had co-infections with multiple HPV types. 95% of multiple infections 
harboured at least one HR-HPV. In the majority of multiple infections (75%) the persistent 
type was HR-HPV type, of them, the most common types were HPV16 (18.2%). 
The prevalence of HR-HPV infection was directly correlated with increasing grade of 
cytological atypia, i.e., 66.6% were detected in ASCUS, 78.6% in LSIL and 88.8% in HSIL. 
Cytological progression into LSIL and HSIL occurred in 33% of women. Eleven cases that 
progressed into HSIL during follow-up.  
The risk of progression in LSIL and HSIL was the highest for infections with HR-
HPVs, whereas cases with LR- and UR-HPVs tended to regress or remained unchanged 
during follow up. There was no significant difference between risk of progression into HSIL 
either among women younger or older than 30 years nor in mono- and multiple infections.  
In histologically proven cases 60% had ≥CIN2/VAIN2 lesions, 36% of them were 
associated with multiple types. 50% of patients  with multiple types had ≥CIN2 lesions and 
harboured persistent HPV16.  In monoinfections 55% of histologically proven ≥CIN2/VAIN2 
cases harboured persistent HPV16.  
 
Summary: Detecting long-term persistent HPV infections by genotyping may help identify 
women with cervical intraepithelial lesions who are at lower and higher risk of developing 
high grade pre-cancer and cancer. 
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III. Morphological spectrum of lesions of the uterine cervix infected by multiple HPV 
genotypes – viral detection 
 
Upon investigating the spectrum of cervical diseases induced by multiple HPV 
genotypes the following lesions were identified: invasive squamous cell cancer, cervical 
intraepithelial neoplasia (CIN1-3) and adenocarcinoma in situ (in two cases). 
In each sample, either classic (koilocytosis, dyskeratocytosis) or a combination of non-
classic (nuclear abnormalities, cytoplasmic abnormalities and disorders of keratinisation, 
suprabasal mitotic figures) histo(cito)morphological HPV signs were detected in a carcinoma 
or dysplastic free, normal appearing or hyperplastic ecto/endocervical epithelium. Based on 
morphology alone, no difference could be made between type specific HPV infections.  
Immunohistochemical (p16INK4a, Mib-1, HPV L1-capsid) and in situ hybridization 
methods were used to visualize the HPV-induced genetic instability resulting in cell-cycle 
disorders and the presence of common high-risk HPV genotypes in dysplastic, minimally 
abnormal and premalignant hyperplastic lesions of the uterine cervix. Biotinylated and 
digoxigenin labelled type specific HPV DNS probes against HPV16 and HPV31 were used 
for detection tissue localisation of different genotypes.  
The variable histomorphological characteristics of HPV infection and the 
topographical distribution of the viri have been compiled in histological graphs (Figure 1).  
 
 
Our morphological observations regarding alterations present in every HPV-infected tissue 
may help the routine diagnostic work by highlighting the etiological role of HPV. 
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SUMMARY OF NEW FINDINGS 
 
1. Our observations may promote better understanding of the epidemiology of HPV 
infections, especially regarding ones caused by multiple genotypes. 
 
2. Our observations seem to validate the theory, that persistent infections of a single genotype 
play a primary role in the pathomechanism of cervical cancer and precancerous lesions. The 
topic of our study is current  (Harald zur Hausen – Medical Nobel Prize 2008), its importance 
regarding people’s health is paramount. 
 
3. We have reflected upon the problematics of virus detection in the cases of multiple HPV 
infections by using molecular biological methods on cytological samples and in situ 
hybridization using histological samples. 
 
4. We have shown the differences between the cummulative prevalance and the cross-
sectional prevalance of single visits, and highlighted the importance of follow-up studies. 
 
5. As far as we know, this is the first dinamic follow-up study of HPV DNA detection and 
genotyping within the setting of routine oncocytological screening regarding persistent HPV 
infections. 
 
6. As far as we know, this is the first hungarian study that describes classical and non-
classical cytomorphological signs of HPV infection at the histological level in cases of 
multiple HPV infections tested by molecular biological methods. Also, this is the first such 
study using immunohistochemistry and in situ hybridisation to detect the presence of HPV 
within both squamous and glandular epithelium and providing evidenced regarding the 
histological distribution of different genotypes in cases with multiple HPV infection. 
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